Advanced Vitreoretinal Techniques & Technology Symposium

Size: px

Start display at page:

Download "Advanced Vitreoretinal Techniques & Technology Symposium"

Shawn Fletcher
5 years ago
Views:

14th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium JULY 25-27, 2014 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT STATEMENT This activity has been planned and

1 14th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium JULY 25-27, 2014 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT STATEMENT This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of William Beaumont Hospital and Medical Conference Planners, Inc. William Beaumont Hospital is accredited by the ACCME to provide continuing medical education for physicians. William Beaumont Hospital designates this live activity for a maximum of AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Credit breakdown: Friday=9.50, Saturday=7.75, Sunday=4.00) Non-physician professionals should check with their individual credentialing bodies to confirm that participation in this CME activity will be approved for credit. CME credits can be used to meet the continuing education requirements for Michigan physician assistant and nursing relicensure without limitation.

SYM P OSIUM FAC ULT Y Assistant Professor of Ophthalmology

Feinberg School of Medicine Northwestern University

of Ophthalmology Rush University Medical Center Retinal

Ophthalmology Research Professor of Ophthalmology,

Institute Professor of Ophthalmology Director, Medical

Center Doheny Eye Institute/UCLA Associate Director, Retina

Science and Engineering Illinois Institute of Technology

and Ear Infirmary Associate Professor, Dept.

LEIDERMAN, MD, PhD Assistant Professor of Ophthalmology

of Ophthalmology William Beaumont Hospital/ Associated

NYU School of Medicine Vitreous Retina Macula Consultants

Infirmary S Y M P O S I U M O R G A N I Z E R Professor of

3 SYM P OSIUM FAC ULT Y Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Professor of Ophthalmology Feinberg School of Medicine Northwestern University Professor & Chairman, Dept. of Ophthalmology Rush University Medical Center Retinal Consultants of Arizona Chaney Family Endowed Chair for Ophthalmology Research Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine Cole Eye Institute Professor of Ophthalmology Director, Medical Retina Unit, Ophthalmic Imaging Unit, Doheny Image Reading Center Doheny Eye Institute/UCLA Associate Director, Retina Service, MEEI S.E. Gragoudas Associate Professor of Ophthalmology Harvard Medical School JENNIFER J. KANG-MIELER, PhD Associate Professor of Biomedical Engineering Dept. of Biomedical Engineering, Pritzker Institute of Biomedical Science and Engineering Illinois Institute of Technology Clinical Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Associate Professor, Dept. of Ophthalmology Feinberg School of Medicine Northwestern University YANNEK I. LEIDERMAN, MD, PhD Assistant Professor of Ophthalmology Illinois Eye and Ear Infirmary Chairman, Dept. of Ophthalmology William Beaumont Hospital/ Associated Retinal Consultants Clinical Professor of Ophthalmology, NYU School of Medicine Vitreous Retina Macula Consultants of New York Professor of Ophthalmology Illinois Eye and Ear Infirmary S Y M P O S I U M O R G A N I Z E R Professor of Ophthalmology, Retina Service Interim Department Head Vice Chair for Education DEBRA A. GOLDSTEIN, MD Professor, Director Uveitis Service Dept. of Ophthalmology Northwestern Memorial Hospital Feinberg School of Medicine Northwestern University Professor of Ophthalmology, Retina Service Interim Department Head Vice Chair for Education A V T T

4 AVTT 2014 PROGRAM FRIDAY, JULY 25 7:00 AM 5:30 PM Registration 7:00 AM 7:55 AM fast 7:00 AM 1:15 PM Exhibits 7:55 AM 12:30 PM Best Practice in Ophthalmology Vitreoretinal Fellows Program 7:55 AM Introduction and Welcome 8:00 AM Ophthalmic Workforce and the Economics of Vitreoretinal Practice 8:15 AM New Payment Methods for Physicians 8:30 AM What is the RUC, and New Issues in Retinal Coding 8:45 AM Improving Patient Satisfaction in Vitreoretinal Practice 9:00 AM Audits: Here, There, and Everywhere 9:15 AM Off-Label Drug Usage and the Law 9:30 AM Risk Management, and Avoiding a Lawsuit 9:45 AM Ethics Round Table with Entire Faculty MODERATOR: 10:00 AM 10:30 AM 10:30 AM Incorporating Clinical Research and Clinical Trials into your Practice 10:45 AM The Current Status of Vitreoretinal Fellowship Accreditation and Certification 11:00 AM : Type of Practice, Pros and Cons of Academics, Private Practice and/or a Mixed Type of Practice, or Being a Chairman? ALL FACULTY 11:15 AM Activity Based Costing: Do You Really Know What is Profitable? 11:30 AM Maintaining Quality in a High Volume Practice Setting 11:45 AM Important Factors to Consider in Choosing a Practice: Contract Management/Partners/Location ALL FACULTY 12:15 PM Advocacy: Why You Should Participate 12:30 PM 1:15 PM Lunch 1:15 PM 5:30 PM Vitrectomy Instrument Demonstration and of Challenging OCT, Medical, and Surgical Cases for the Vitreoretinal Fellows (Vitreoretinal Fellows and Residents will be separated into two groups for the interactive sessions.) GROUP 1 1:15 PM 3:15 PM Vitrectomy Instrument Demonstration 3:15 PM 3:30 PM 3:30 PM 5:30 PM of OCT, Medical and Surgical Cases 4 A V T T 2 014

5 GROUP 2 1:15 PM 3:15 PM of OCT, Medical and Surgical Cases 3:15 PM 3:30 PM 3:30 PM 5:30 PM Vitrectomy Instrument Demonstration 5:30 PM 7:00 PM Hands-on Vitrectomy Instrument Usage and Reception ALL FACULTY SATURDAY, JULY 26 6:45 AM 5:00 PM Registration 6:45 AM 7:25 AM fast 6:45 AM 5:00 PM Exhibits 7:25 AM 9:30 AM Retinal Imaging and Technology MODERATOR: 7:25 AM Introduction 7:30 AM OCT and the Next Generation of OCT (Swept Source) 7:45 AM EDI-OCT: How Helpful is it in the Management of Choroidal Disease? 8:00 AM OCT of Vitreomacular Interface Disorders 8:15 AM Fundus Autofluorescence in Clinical Practice 8:30 AM The Utility of Wide-Angle Imaging (Is it Essential for Practice?) 8:45 AM Doppler OCT: Functional Imaging of Blood Flow 9:00 AM Multi-Modal Imaging of White Spot Syndromes; Is it Helpful in Diagnosis and Treatment? 9:15 AM Image Management Solutions for a Busy Practice 9:30 AM 10:00 AM 10:00 AM 10:30 AM Vitreoretinal Surgery and Techniques MODERATOR: 10:00 AM Fluidics, Tips and Tricks for Small Gauge Vitrectomy Surgery 10:15 AM Management of Silicone Oil: Getting it Just Right 10:30 AM Combination PPV and Cataract Surgery; Are Outcomes of Combination or Sequential Surgery Different? 10:45 AM Retinal Techniques for IOL Re-positioning and/or Replacement 11:00 AM The Timing of Surgery for Repair of a Primary Retinal Detachment 11:15 AM Repair of Retinal Detachment after Open-Globe Injury 11:30 AM 11:45 AM DEBATE #1: Initial Treatment of a Macular Hole with Vitreomacular Adhesion MODERATOR: A V T T

6 11:30 AM Pharmacologic Vitreolysis 11:35 AM Vitrectomy Surgery 11:40 AM 11:45 AM 12:00 PM DEBATE #2: High-Speed (>5000 cpm) and Small Gauge (27 gauge) Vitrectomy Machines Have Revolutionized Our Surgery and Improved Our Outcomes MODERATOR: 11:45 AM PRO: Our Outcomes Have Been Dramatically Improved 11:50 PM CON: The High-Speed Machines Have Minimally Enhanced Our Outcomes 11:55 PM 12:00 PM 1:00 PM Lunch 1:00 PM 3:00 PM Diabetic Retinopathy and DME MODERATOR: 1:00 PM Pathophysiology of Diabetic Retinopathy 1:15 PM DRCR: Past, Present and Future 1:30 PM Treatment Algorithm for DME 1:45 PM Corticosteroid Drug Delivery Devices: Paradigm Shift in the Management of DME? 2:00 PM Surgery for DME: Is it Beneficial? 2:15 PM Surgical Treatment of Proliferative Diabetic Retinopathy 2:30 PM Evidence Based Treatment for DME: What is Truly Cost Effective? 2:45 PM Systemic Safety of Anti-VEGF Therapy: Is There Cause for Concern? 3:00 PM 3:30 PM 3:30 PM 3:45 PM VASCULAR DISEASE DEBATE #1: What Determines the Need for Initial Treatment of Diabetic Macular Edema? MODERATOR: 3:30 PM OCT 3:35 PM Visual Acuity 3:40 PM 3:45 PM Update Regarding Treatment of Venous Occlusive Disease 4:00 PM 4:15 PM VASCULAR DISEASE DEBATE #2: Initial Treatment of Venous Occlusive Disease MODERATOR: 4:00 PM Anti-VEGF Therapy All the Way 4:05 PM Corticosteroids are the Best Starting Medication 4:10 PM 4:15 PM 5:15 PM Miscellaneous MODERATOR: 4:15 PM Pediatric Retina Update 4:30 PM Adult ROP 6 A V T T 2 014

7 4:45 PM Uveal Melanoma Update 5:00 PM More OCT Mystery Cases 5:15 PM 6:15 PM Reception SUNDAY, JULY 27 6:45 AM 12:00 PM Registration 6:45 AM 7:25 AM fast 6:45 AM 10:00 AM Exhibits 7:25 AM 9:30 AM AMD and Retinal Degenerations MODERATOR: 7:25 AM Introduction 7:30 AM AREDS2 Update 7:45 AM New Drugs in the Pipeline for Dry AMD (Is a Significant through Coming Soon?) 8:00 AM New Drugs in the Pipeline for Wet AMD (Beyond Anti-VEGF) 8:15 AM En Face OCT Findings in AMD and Reticular Pseudodrusen 8:30 AM The Role of Imaging in the Management of AMD 8:45 AM New Findings in Polypoidal Vasculopathy 9:00 AM Gene Therapy, Artificial Vision and the Argus II Implant 9:15 AM Drug Delivery Systems Update JENNIFER J. KANG-MIELER, PhD 9:30 AM 10:00 AM 10:00 AM 10:15 AM DEBATE: Genetic Testing and AMD MODERATOR: PRAVIN U. DUGEL 10:00 AM PRO: Genetic Testing Should Routinely be Performed for AMD as it Impacts Potential Management 10:05 AM CON: Genetic Testing is Currently NOT Indicated 10:10 AM 10:15 AM 12:00 PM Infection and Inflammation MODERATOR: 10:15 AM Endophthalmitis Update :30 AM The Nuances of Safely Giving an Intravitreal Injection 10:45 AM What s New in Intravitreal Therapy for Uveitis? DEBRA A. GOLDSTEIN, MD 11:00 AM Ocular Lymphoma: Varying Clinical Manifestations 11:15 AM Ocular Lymphoma: Confirmation of Diagnosis, and Treatment 11:30 AM Ocular Manifestations of Tuberculosis DEBRA A. GOLDSTEIN, MD 11:45 AM The Numerous Manifestations of Ocular Syphilis DEBRA A. GOLDSTEIN, MD 12:00 PM Meeting Adjourned A V T T

8 This CME activity is supported by an educational grant from: E X H I B I TO R S AVTT acknowledges generous contributions from the following companies: PLATINUM Genentech, Inc. GOLD Regeneron Pharmaceuticals, Inc. SILVER Alcon Laboratories, Inc. Allergan, Inc. Insight Instruments, Inc. OCULUS Surgical, Inc. Quantel Medical, Inc. Synergetics, Inc. Medical Conference Planners, Inc avtt@medconfs.com

Advanced Vitreoretinal Techniques & Technology Symposium

15th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium AUGUST 28-30, 2015 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT DESIGNATION This activity has been planned and implemented